These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28421881)

  • 1. Factors pivotal for designing of nanoantimicrobials: an exposition.
    Jamil B; Imran M
    Crit Rev Microbiol; 2018 Feb; 44(1):79-94. PubMed ID: 28421881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety Assessment of Nanomaterials for Antimicrobial Applications.
    Ali A; Ovais M; Cui X; Rui Y; Chen C
    Chem Res Toxicol; 2020 May; 33(5):1082-1109. PubMed ID: 32302095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
    Wong JP; DiTullio P; Parkinson S
    Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to prevent the occurrence of resistance against antibiotics by using advanced materials.
    Bassegoda A; Ivanova K; Ramon E; Tzanov T
    Appl Microbiol Biotechnol; 2018 Mar; 102(5):2075-2089. PubMed ID: 29392390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of biofilm-associated infections by signaling molecules and nanoparticles.
    Holban AM; Gestal MC; Grumezescu AM
    Int J Pharm; 2016 Aug; 510(2):409-18. PubMed ID: 26945736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi for silencing drug resistance in microbes toward development of nanoantibiotics.
    Edson JA; Kwon YJ
    J Control Release; 2014 Sep; 189():150-7. PubMed ID: 24995951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria.
    Rai MK; Deshmukh SD; Ingle AP; Gade AK
    J Appl Microbiol; 2012 May; 112(5):841-52. PubMed ID: 22324439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
    Engin AB; Engin A
    Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies targeting persister cell formation in bacterial pathogens.
    Khan F; Pham DTN; Tabassum N; Oloketuyi SF; Kim YM
    Crit Rev Microbiol; 2020 Nov; 46(6):665-688. PubMed ID: 33022189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofilm-related disease.
    Del Pozo JL
    Expert Rev Anti Infect Ther; 2018 Jan; 16(1):51-65. PubMed ID: 29235402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persister cells, dormancy and infectious disease.
    Lewis K
    Nat Rev Microbiol; 2007 Jan; 5(1):48-56. PubMed ID: 17143318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance.
    Frieri M; Kumar K; Boutin A
    J Infect Public Health; 2017; 10(4):369-378. PubMed ID: 27616769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.